(Q73261975)

English

Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part I. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers

scientific article published on 01 December 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10593371%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part I. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10593371%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

bioavailability

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

J J Oberyé

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10593371%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

B M Mannaerts

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10593371%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H J Kleijn

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10593371%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C J Timmer

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10593371%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10593371%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Fertility and Sterility

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10593371%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

72

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10593371%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10593371%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1001-1005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10593371%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Gonadotropin-releasing hormone and its analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900413-6

7 January 2021

Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix).

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900413-6

7 January 2021

Dose-related suppression of serum luteinizing hormone in women by a potent new gonadotropin-releasing hormone antagonist (Ganirelix) administered by intranasal spray

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900413-6

7 January 2021

Radioimmunoassay of ganirelix in plasma or serum

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900413-6

7 January 2021

Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900413-6

7 January 2021

Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900413-6

7 January 2021

Identifiers

10.1016/S0015-0282(99)00413-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10593371%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10593371%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73261975&oldid=2143855719"